Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more
Amplitude Surgical SAS (AMPLI) - Total Liabilities
Latest total liabilities as of December 2024: €184.97 Million EUR
Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) has total liabilities worth €184.97 Million EUR as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Amplitude Surgical SAS - Total Liabilities Trend (2011–2024)
This chart illustrates how Amplitude Surgical SAS's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Amplitude Surgical SAS Competitors by Total Liabilities
The table below lists competitors of Amplitude Surgical SAS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Heritage Distilling Holding Company, Inc. Common Stock
NASDAQ:CASK
|
USA | $29.42 Million |
|
Daedong Steel Co. Ltd
KQ:048470
|
Korea | ₩25.08 Billion |
|
Bitmis Corp
PINK:BIMT
|
USA | $3.34 Million |
|
Kingfish Company Nv
OL:KING
|
Norway | Nkr122.14 Million |
|
Young Poong Pa
KO:006740
|
Korea | ₩81.30 Billion |
|
Tela Bio Inc
NASDAQ:TELA
|
USA | $60.03 Million |
|
Dong Won Fish
KO:030720
|
Korea | ₩61.83 Billion |
|
Indiana Resources Limited
PINK:GSMGF
|
USA | $922.00K |
Liability Composition Analysis (2011–2024)
This chart breaks down Amplitude Surgical SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.04 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amplitude Surgical SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amplitude Surgical SAS (2011–2024)
The table below shows the annual total liabilities of Amplitude Surgical SAS from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | €183.43 Million | +7.77% |
| 2023-06-30 | €170.20 Million | -17.73% |
| 2022-06-30 | €206.89 Million | -2.50% |
| 2021-06-30 | €212.21 Million | +3.87% |
| 2020-06-30 | €204.29 Million | +5.07% |
| 2019-06-30 | €194.43 Million | +0.47% |
| 2018-06-30 | €193.52 Million | +15.31% |
| 2017-06-30 | €167.82 Million | +20.61% |
| 2016-06-30 | €139.15 Million | +8.44% |
| 2015-06-30 | €128.31 Million | -15.93% |
| 2014-06-30 | €152.62 Million | +26.27% |
| 2013-06-30 | €120.87 Million | +12.08% |
| 2012-06-30 | €107.84 Million | +8.33% |
| 2011-06-30 | €99.55 Million | -- |